Related Experiment Video
Updated: Mar 5, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.3K
Implementing an online pharmaceutical service using design science research
Luís Velez Lapão1, Miguel Mira da Silva2, João Gregório3
1Global Health and Tropical Medicine (GHTM), WHO Collaborating Center for Health Workforce Policy and Planning, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Rua da Junqueira, n° 100, Lisboa, 1349-008, Portugal. luis.lapao@ihmt.unl.pt.
BMC Medical Informatics and Decision Making
|March 29, 2017
Summary
This study introduces ePharmacare, an online pharmaceutical service designed to manage chronic diseases. Findings reveal patient demand for online pharmacy services, but pharmacist adoption is hindered by time constraints and a lack of information system skills.
Area of Science:
- Health Informatics
- Pharmaceutical Services
- Digital Health
Background:
- Rising chronic disease prevalence necessitates health system reforms.
- Primary healthcare and multidisciplinary models are proposed solutions.
- eHealth and online pharmaceutical services offer potential improvements but face adoption challenges.
Purpose of the Study:
- To present ePharmacare, a novel online pharmaceutical service.
- To implement the service using Design Science Research Methodology (DSRM).
- To investigate the adoption of online pharmaceutical services by pharmacists and patients.
Main Methods:
- Design Science Research Methodology (DSRM) guided the project.
- Requirements were gathered through surveys, observations, focus groups, and eye-tracking.
- The ePharmacare service was demonstrated and evaluated with real users.
Main Results:
- DSRM effectively contributed to implementing online pharmacy services.
- Pharmacists dedicate only 50% of their time to patient interaction, indicating service potential.
- Patients value continuity of care and desire online pharmacy interaction channels.
Conclusions:
- The study successfully proposed, designed, developed, and evaluated an online pharmaceutical service using DSRM.
- Key barriers to pharmacist adoption include time constraints, time management, IT skills, and role definition.
- Future work should focus on training and service reorganization to address adoption barriers.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
389
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
389
01:26Drug Administration and Therapy Phases: Overview
1.6K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.7K
01:26Drug Discovery: Overview
12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K
01:28Dosage Regimens: Designs and Approaches
406
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
406